PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 134 filers reported holding PDL BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $34,000 | -94.3% | 11,940 | -93.5% | 0.00% | -91.2% |
| Q4 2019 | $592,000 | -47.2% | 182,510 | -64.9% | 0.03% | -35.8% |
| Q3 2019 | $1,122,000 | -34.6% | 519,315 | -5.0% | 0.05% | -30.3% |
| Q2 2019 | $1,716,000 | +342.3% | 546,487 | +424.3% | 0.08% | +406.7% |
| Q1 2019 | $388,000 | +28.5% | 104,240 | 0.0% | 0.02% | +25.0% |
| Q4 2018 | $302,000 | -76.1% | 104,240 | -77.4% | 0.01% | -69.2% |
| Q4 2017 | $1,263,000 | +742.0% | 461,100 | +2184.9% | 0.04% | +875.0% |
| Q3 2014 | $150,000 | -47.9% | 20,180 | -32.4% | 0.00% | -50.0% |
| Q2 2014 | $288,000 | +10.8% | 29,850 | -4.9% | 0.01% | +14.3% |
| Q1 2014 | $260,000 | -0.4% | 31,375 | +1.4% | 0.01% | -12.5% |
| Q4 2013 | $261,000 | – | 30,950 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |